Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Deep Vein Thrombosis
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study seeks to determine the rate of thromboembolic complications (blood clots), including death attributed to thromboembolic disease, when anticoagulation (blood thinner) therapy is withheld from pregnant patients suspected of deep vein thrombosis (DVT) after a whole-leg compression ultrasound shows no DVT. Patients are followed for three months after the ultrasound to determine if a blood clot is diagnosed during that time.

Provided treatments

  • Other: Whole-leg compression ultrasound
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319474. The sponsor of the trial is Intermountain Health Care, Inc. and it is looking for 268 volunteers for the current phase.
Official trial title:
Use of Whole-leg Ultrasound for Diagnosis of Deep Vein Thrombosis in Pregnant Patients